Sanofi India posted results showing net profit and revenue growth YoY, but the company also showed a decline in operating profit margins, of 5.7% YoY. Potential impact on margins was likely from rupee depreciation, with Sanofi seeing recent quarter growth from export markets. Sanofi India imports specific products such as Lantus (insulin injections) from its group company, that it sells in Indian markets, while exports from Sanofi India have been targeted at semi-regulated developing countries. 

Textile company Sumeet Industries also posted quarterly results. The company's performance was disappointing, showing declines in YoY performance across the board, and a sharp fall in operating margins.